Cargando…
Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies
Hepatitis C virus (HCV) accounts for 15%–20% of cases of acute infection, and chronic HCV infection is developed in about 50%–80% of HCV patients. Unfortunately, due to the lack of proper medical care, difficulty in screening for HCV infection, and lack of awareness resulted in chronic HCV infection...
Autores principales: | Warkad, Shrikant Dashrath, Song, Keum-Soo, Pal, Dilipkumar, Nimse, Satish Balasaheb |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806196/ https://www.ncbi.nlm.nih.gov/pubmed/31575036 http://dx.doi.org/10.3390/s19194257 |
Ejemplares similares
-
HCV Detection, Discrimination, and Genotyping Technologies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2018) -
Development of a Method for Screening and Genotyping
of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2020) -
ID-Checker Technology
for the Highly Selective Macroscale
Delivery of Anticancer
Agents to the Cancer Cells
por: Song, Keum-soo, et al.
Publicado: (2022) -
A Novel Method That Allows SNP Discrimination with 160:1 Ratio for Biosensors Based on DNA-DNA Hybridization
por: Nimse, Satish Balasaheb, et al.
Publicado: (2021) -
Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure
por: Song, Keum-Soo, et al.
Publicado: (2017)